Home » Business » Manufacturing
Drug firm expects growth to double
By Ding Yining |
March 1, 2012, Thursday
|
Print Edition
Print Edition
BRISTOL-MYERS Squibb yesterday said it expects its China sales to grow by 27 percent this year, double the growth in 2011, based on strong demand for its key hepatitis and diabetes products.
Last year, its sales in China grew 13 percent annually, beating its global growth of 9 percent.
"We plan to introduce at least two new prescription drugs to the Chinese market this year and focus on getting more new innovative products registered in China," Jean-Christophe Pointeau, president of BMS China, said yesterday.
Last year, its sales in China grew 13 percent annually, beating its global growth of 9 percent.
"We plan to introduce at least two new prescription drugs to the Chinese market this year and focus on getting more new innovative products registered in China," Jean-Christophe Pointeau, president of BMS China, said yesterday.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
